<--- Back to Details
First PageDocument Content
Institutional investors / Ribbon symbolism / Life insurance / Management of cancer / Insurance / Breast cancer / Prostate cancer / Radiation therapy / Critical illness insurance / Medicine / Health / Financial institutions
Date: 2013-05-14 16:39:30
Institutional investors
Ribbon symbolism
Life insurance
Management of cancer
Insurance
Breast cancer
Prostate cancer
Radiation therapy
Critical illness insurance
Medicine
Health
Financial institutions

SERFF Tracking #: SEFL[removed]State Tracking #:

Add to Reading List

Source URL: disb.dc.gov

Download Document from Source Website

File Size: 639,53 KB

Share Document on Facebook

Similar Documents

Journal of Machine Learning ResearchSubmitted 8/15; Revised 3/16; PublishedStructure-Leveraged Methods in Breast Cancer Risk Prediction

DocID: 1vq0d - View Document

Multicausality: Confounding - Assignment solutions 1. a. Reserpine is a risk factor. Overall, the incidence of breast cancer isper 100,000 women-years in reserpine users and 6.14 per 100,000 women-years in nonuser

DocID: 1vpNA - View Document

Frequently Asked Questions: Trainees seeking a PhD education in Cancer Biology or a related area with a focus on Breast Cancer Health Disparities. 1. What is the Komen Graduate Training in Disparities Research Grant (GT

DocID: 1voV1 - View Document

_____________________________________________________________ What to Do When Someone You Know Has Been Diagnosed with Breast Cancer [Last revised Mar 2014]

DocID: 1vlqg - View Document

Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1–mediated metabolism to the product 4′ hydroxy tangeretin

DocID: 1vl9e - View Document